Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Predicting Pseudophakic Refractive Error
  • Refractive Surgery/Vision Correction

Predicting Pseudophakic Refractive Error

Ophthalmology 360
Article Image

What is the best way to predict pseudophakic refractive error in patients who are about to undergo cataract surgery? Investigators recently sought the answer by conducting a prospective case series involving 100 individuals. 

Investigators calculated optimum intraocular lens (IOL) power and predicted refractive outcomes using the Barrett Universal II, Hill-RBF, and SRK/T formulas.  They then compared the predicted refraction with objective refractive outcomes 1 week, 1 month, and 3 months after surgery. Among the results: 

  • Average axial length was 23.4 mm, and mean keratometry was 43.9 diopters. 
  • Average prediction errors at 3 months were 0.50, 0.49, and 0.52 D, respectively. 
  • Universal II served as a better predictor than the others at 1 week.
  • All methods performed similarly at 1 and 3 months. 
  • RBF predicted the highest proportion of eyes within ±0.25 D at 3 months. 
  • Keratometric changes primarily occurred 1 to 4 weeks postop.
  • A significant hyperopic shift was seen 4 to 12 weeks postop. 

Wallace H, Misra S, Li S, McKelvie J. Predicting pseudophakic refractive error: Interplay of biometry prediction error, anterior chamber depth, and changes in corneal curvature.  [Published online ahead of print August 2, 2018]. J Cataract Refract Surg. doi:  https://doi.org/10.1016/j.jcrs.2018.06.017. 
 

Share

Related Content

  • Refractive Surgery/Vision Correction

VISUMAX 800 lenticule extraction linked to high satisfaction and spectacle independence

  • Refractive Surgery/Vision Correction

First-in-human study underway for non-invasive vision correction technology

  • Refractive Surgery/Vision Correction

Tips to successfully integrate EVO ICL into office-based surgery

Dr. Ling implanting EVO ICL
  • Refractive Surgery/Vision Correction

EVO ICL plays a strategic role in my refractive business model

  • Cornea and External Disease

Who is the ideal candidate for EVO ICL?

  • Cornea and External Disease

Impact of corneal size on refractive surgery outcomes highlighted in new research

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon